Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia (2017)
- Authors:
- Autor USP: REGO, EDUARDO MAGALHÃES - FMRP
- Unidade: FMRP
- DOI: 10.1182/bloodadvances.2017005926
- Subjects: LEUCEMIA MIELOIDE AGUDA; EXPRESSÃO GÊNICA; REAÇÃO EM CADEIA POR POLIMERASE
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2017
- Source:
- Título: Blood Advances
- ISSN: 2473-9537
- Volume/Número/Paginação/Ano: v. 1, n. 21, p. 1807-1814, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LUCENA-ARAUJO, Antonio R. et al. Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia. Blood Advances, v. 1, n. 21, p. 1807-1814, 2017Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2017005926. Acesso em: 27 jan. 2026. -
APA
Lucena-Araujo, A. R., Pereira-Martins, D. A., Koury, L. C., Franca-Neto, P. L., Coelho-Silva, J. L., Wagatsuma, V. M. de D., et al. (2017). Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia. Blood Advances, 1( 21), 1807-1814. doi:10.1182/bloodadvances.2017005926 -
NLM
Lucena-Araujo AR, Pereira-Martins DA, Koury LC, Franca-Neto PL, Coelho-Silva JL, Wagatsuma VM de D, Melo RAM, Bittencourt R, Pagano K, Rego EM. Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia [Internet]. Blood Advances. 2017 ; 1( 21): 1807-1814.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/bloodadvances.2017005926 -
Vancouver
Lucena-Araujo AR, Pereira-Martins DA, Koury LC, Franca-Neto PL, Coelho-Silva JL, Wagatsuma VM de D, Melo RAM, Bittencourt R, Pagano K, Rego EM. Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia [Internet]. Blood Advances. 2017 ; 1( 21): 1807-1814.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/bloodadvances.2017005926 - Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience
- Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
- Combining gene mutation with gene expression data improves outcomes prediction in acute promyelocytic leukemia
- Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- Granulocyte colony-stimulating factor and leukemogenesis
- Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
- Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
- Hematopoese: cinética de hemácias, neutrófilos e plaquetas
- Epidemiology and treatment of acute promyelocytic leukemia in Latin America
- Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR'alfa', PLZF/RAR'alfa' or NPM/RAR'alfa'
Informações sobre o DOI: 10.1182/bloodadvances.2017005926 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
